ArgenTag
New York
About ArgenTag
We are a biotech startup democratizing genomic sequencing applications with proprietary technology. We developed a reliable and robust solution to bring down the cost of applications in long-read sequencers. Our solution consists in a proprietary technology that enables the invention of a myriad of new long-read applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Pre-Seed (Apr 2023)
- Website: argentag.com
- Phone: [email protected]
Industries & Categories
Bioinformatics, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/argentag-2229669 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.